erythropoietin
美 
英 [ɪrɪθrə'pɔɪətɪn]
- n.红细胞生成素；〔生化〕促红细胞；促红素
- 网络红血球生成素；促红细胞生成素；红血球生长激素
英汉解释
英英解释
例句
Because we've learned about that biology we've been able to make erythropoietin outside the body and use it as a drug.
由于我们已经知道了这种生物学机制，因此我们能体外制造促红细胞生成素，并作为药品应用
BACKGROUND: Recombinant human erythropoietin is commonly used for treatment of anaemia.
背景：重组体人红细胞生成素通常用于治疗贫血。
The stimulating effect of recombinant-erythropoietin (EPO-A) on erythropoiesis has raised interest in its administration as an alternative.
因而重组促红细胞生成素对红细胞生成的刺激作用作为一种替代方法引起了人们的关注。
Millions of cancer and kidney disease patients take ESAs, man-made versions of a human hormone called erythropoietin.
上百万癌症和肾脏疾病患者服用ESA，这种人造荷尔蒙能提高红血球数量。
However, the role of erythropoietin and its underlying mechanism in macrophage foam cell formation are poorly understood.
但是，在巨噬细胞形成泡沫细胞过程中，促红细胞生成素的作用及机制并不清楚。
Background: Erythropoietin is a naturally occurring hormone with multiple effects on a number of different cell types.
背景资料：促红细胞生成素是一种天然存在的激素，对能对各种不同的细胞发挥多种作用。
Continuous erythropoietin receptor activator(CERA) is a third-generation erythropoiesis-stimulating agents(ESA).
持续型EPO受体激活剂（CERA）是新出现的一种第三代红细胞生成刺激剂（ESA）。
Ortho Biotech, for example, recently changed one of the chemicals added to its erythropoietin alpha medicine as a stabilizer.
举例来说，美国奥多生物科技公司最近换了加在红血球生成素里头的一种安定剂。更详细。
Authors analysed concentration of erythropoietin (EPO) in fetal blood from pregnancies complicated by serologic conflict.
作者分析了浓度的红细胞生成素（EPO）在胎血从怀孕复杂血清冲突。
through the secretion of erythropoietin production, and promote bone marrow hematopoiesis.
通过分泌促红细胞生产素，促进骨髓造血。
hemoglobin levels in the US end-stage renal disease population have steadily increased since recombinant erythropoietin became available.
自从重组促红细胞生成素应用以来，美国终末期肾脏疾病患者的血红蛋白水平稳步上升。
Objective: To approach clinical application of erythropoietin in management of anemia in malignancy hematologic disease.
目的：探讨促红细胞生成素在治疗恶性血液病患者贫血中的临床应用。
The benefits of recombinant human erythropoietin treatment in this patient population have been well shown.
的好处，重组人红细胞生成素治疗的病人以及人口已显示。
ConclusionAnemia is not related with iron metabolism in vivo in patients who has urinemia, the main reason is lacking of erythropoietin.
结论：尿毒症患者贫血的发生与体内铁代谢无关，其贫血的主要原因在于促红细胞生成素缺乏。
This invention relates to a kind of protein that possesses erythropoietin activity and its preparation.
本发明涉及一种具有促红细胞生长因子活性的蛋白质及其制备方法。
RESULTS Recombinant human erythropoietin injection in 150-fold dilution had no interference to the bacterial endotoxin test.
结果重组人红细胞生成素注射液稀释150倍对细菌内毒素检查法无干扰。
Recent data have suggested neuroprotective and perhaps even neurotrophic roles for erythropoietin.
最新资料认为促红细胞生成素在神经保护和神经再生方面亦发挥作用。
Effects of erythropoietin or nitric oxide synthesis inhibitor on hyperdynamic circulatory state in cirrhotic rats.
促红细胞生成素与一氧化氮合酶抑制剂对肝硬化大鼠高动力循环状态的影响。
Released kidney lysosomal enzymes may be concerned in the generation of erythropoietin.
释放的肾脏溶酶体的酶可能与产生促红细胞生成素有关。
Erythropoietin, the principal regulator of erythroids progenitor cells, is widely used to treat anemia caused by many diseases.
促红细胞生成素是一种造血因子，临床中广泛应用于治疗各种原因造成的贫血。
Apart from the red cell surface, erythropoietin 's receptor (Epo-R) is also expressed in a large variety of normal tissues.
促红细胞生成素的受体除分布在红血球表面外，也在大批正常组织表达。
Objective: To investigate in vitro release characteristics of collagen double layer minipellet of erythropoietin(EPO).
目的：对红细胞生成素胶原蛋白双层微条的体外释放特性进行研究。
Erythropoietin has been shown to shorten survival in cancer patients under certain circumstances.
促红细胞生成素已被证明缩短癌症患者的存活率在某些情况下。
The IOC Medical Commission has approved a test to detect the use of the banned synthetic hormone erythropoietin, or EPO.
国际奥委会药物委员会已经通过了一项测试来检测违禁使用合成激素红细胞生成素（简称EPO）的情况。
The invention discloses a blood brain barrier penetrable erythropoietin (EPO) which belongs to the field of biological pharmacy.
本发明公开了一种血脑屏障穿透性促红细胞生成素，属于生物制药领域。
In addition, the kidney also has control of blood pressure, stimulating erythropoietin, and maintain an important role in bone health.
此外，肾脏还具有控制血压、刺激红细胞生成、保持骨骼健康等重要作用。
The most frequent causes of PTA were erythropoietin (EPO) and iron deficiency.
导致PTA最常见的原因是红细胞生成素（EPO）和缺铁。
During latest years, recombinant human erythropoietin (rHuEPO) has received attention to the influence of human immune system.
近年来，重组人促红细胞生成素对人体免疫系统的影响开始受到重视。
Hepatology Digest: What about in China and the use of erythropoietin?
国际肝病：在中国促红细胞生成素的应用如何？
Clinic study of erythropoietin therapy and autohemotherapy in the child cardiac operation
小儿心脏手术促红细胞生成素治疗和术前自体献血的临床研究
New Preparation of Recombinant Human Erythropoietin and Study of Its Stability
重组人红细胞生成素新制剂及其稳定性研究
Clinical Study of Recombinant Human Erythropoietin in Preventing and Treating Anemia of Prematurity in Very Low Birth Weight Infants
重组人类促红细胞生成素防治极低出生体重儿贫血的临床研究
Clinical comparison study of recombinant human erythropoietin in preventing anemia of very-low-birth-weight infants
重组人类促红细胞生成素预防极低出生体重儿贫血的研究
Comparing and Analysis of the Quality Standards of Recombinant Human Erythropoietin Both in European Pharmacopoeia and Chinese Pharmacopoeia
重组人促红细胞生成素在国内外药典中质量标准不同点的对比分析
Clinical study of mRNA expression of erythropoietin receptor before and after renal transplantation
肾移植前后骨髓红细胞生成素受体基因表达的临床研究
An experimental study of recombinant human erythropoietin on the treatment of acute myocardial infarction in rats
重组人红细胞生成素对心肌梗死治疗作用的实验研究
Study of the relationship between serum erythropoietin and carcinous anemia
癌性贫血与血清促红细胞生成素关系研究
Clinical study of recombinant human erythropoietin used in 21 perioperative patients
围手术期应用重组人促红细胞生成素21例的经验
Study of Correlation between Serum Erythropoietin and Hemoglobin in Anemic Patients of Chronic Renal Failure
慢性肾衰患者促红细胞生成素与血红蛋白的相关性研究
An experimental study of recombinant human erythropoietin in the treatment of acute myocardial infarction in rats
重组人红细胞生成素对大鼠心肌梗死的治疗作用
